Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with
Brian W McCrindle1, Victor Zak, Lynn A Sleeper
1Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8. brian.mccrindle@sickkids.ca
Insights
Functional health status in Fontan procedure patients is not strongly predicted by common laboratory measures. These findings suggest laboratory values may not be ideal surrogate endpoints for clinical trials in this population.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Fontan Procedure Outcomes
Background:
- Patients undergoing the Fontan procedure face risks of diminished functional health.
- Understanding associations between laboratory measures and health status is crucial for interventions and clinical trial outcomes.
Purpose of the Study:
- To investigate the relationship between functional health status and various laboratory and imaging measures in Fontan procedure survivors.
- To determine if laboratory measures can serve as effective surrogate endpoints in clinical trials.
Main Methods:
- Utilized the Child Health Questionnaire (CHQ) to assess functional health status in 511 Fontan patients (aged 6-18).
- Performed regression analyses to correlate CHQ Physical and Psychosocial Functioning Summary Scores (FSS) with exercise testing, echocardiography, MRI, and brain natriuretic peptide levels.
Main Results:
- Higher Physical FSS was weakly associated with higher maximum work rate on exercise tests (9% variation).
- Echocardiographic factors (lower Tei index, lower end-systolic volume, absence of AV regurgitation) and MRI findings (lower mass to end-diastolic volume ratio) correlated with better Physical FSS (14% and 11% variation, respectively).
- Brain natriuretic peptide showed a weak association with Physical FSS (1% variation); psychosocial functioning had fewer and weaker associations with laboratory measures.
Conclusions:
- Laboratory measures explain only a small portion of the variation in functional health status among relatively healthy Fontan patients.
- Current laboratory measures may not be optimal surrogate endpoints for evaluating therapeutic interventions in Fontan survivors.
Background:
Patients after the Fontan procedure are at risk for suboptimal functional health status, and associations with laboratory measures are important for planning interventions and outcome measures for clinical trials.
Methods And Results:
Parents completed the generic Child Health Questionnaire for 511 Fontan Cross-Sectional Study patients 6 to 18 years of age (61% male). Associations of Child Health Questionnaire Physical and Psychosocial Functioning Summary Scores (FSS) with standardized measurements from prospective exercise testing, echocardiography, magnetic resonance imaging, and measurement of brain natriuretic peptide were determined by regression analyses. For exercise variables for maximal effort patients only, the final model showed that higher Physical FSS was associated only with higher maximum work rate, accounting for 9% of variation in Physical FSS. For echocardiography, lower Tei index (particularly for patients with extracardiac lateral tunnel connections), lower indexed end-systolic volume, and the absence of atrioventricular valve regurgitation for patients having Fontan procedure at age <2 years were associated with higher Physical FSS, accounting for 14% of variation in Physical FSS. For magnetic resonance imaging, ratio of lower mass to end-diastolic volume and midquartiles of indexed end-systolic volume (nonlinear) were associated with higher Physical FSS, accounting for 11% of variation. Lower brain natriuretic peptide was significantly but weakly associated with higher Physical FSS (1% of variation). Significant associations for Psychosocial FSS with laboratory measures were fewer and weaker than for Physical FSS.
Conclusions:
In relatively healthy Fontan patients, laboratory measures account for a small proportion of the variation in functional health status and therefore may not be optimal surrogate end points for trials of therapeutic interventions.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology


